NRIX
Nurix Therapeutics Inc
NASDAQ: NRIX · HEALTHCARE · BIOTECHNOLOGY
$27.26
+2.10% today
Updated 2026-10-28
Market cap
$2.67B
P/E ratio
10.05
P/S ratio
3.80x
EPS (TTM)
$2.43
Dividend yield
—
52W range
$10 – $28
Volume
1.9M
Nurix Therapeutics Inc (NRIX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$27.26
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 10.05x (capped 25x) · Margin: 42.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.